Clinical Trial Update: Milk-only Lactation Study for Patients on Eltrombopag [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating a milk-only lactation protocol for patients on eltrombopag has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Thrombocytopaenia | Phase 4 | Status: WITHDRAWN